These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2031840)

  • 1. Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis.
    Fabris F; Cordiano I; Randi ML; Casonato A; Montini G; Zacchello G; Girolami A
    Pediatr Nephrol; 1991 Mar; 5(2):225-8. PubMed ID: 2031840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of erythropoietin on platelet function in uraemic children on haemodialysis.
    Turi S; Soos J; Torday C; Bereczki C; Havass Z
    Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients.
    van Geet C; Hauglustaine D; Verresen L; Vanrusselt M; Vermylen J
    Thromb Haemost; 1989 Feb; 61(1):117-21. PubMed ID: 2749585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
    Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
    Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse relationships between haemoglobin and ristocetin-induced platelet aggregation in haemodialysis patients under erythropoietin therapy.
    Borawski J; Rydzewski A; Mazerska M; Kalinowski M; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 1996 Dec; 11(12):2444-8. PubMed ID: 9017620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E; Nabeshima K; Niikura K; Kawabe S; Akizawa T; Kitaoka T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1109-16. PubMed ID: 2287103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia].
    Mazerska M; Pawlak K; Azzadin A; Małyszko J; Małyszko J; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1992 Oct; 88(4):230-7. PubMed ID: 1488323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.
    Akizawa T; Kinugasa E; Kitaoka T; Koshikawa S
    Nephron; 1991; 58(4):400-6. PubMed ID: 1922603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
    Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
    Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
    Bartůnková J; Sulková S; Cebecauer M
    Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis].
    Sułowicz W; Hanicki Z; Skotnicki AB; Wójcik J; Sydor A
    Przegl Lek; 1992; 49(3):88-90. PubMed ID: 1438902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
    Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
    Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
    Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
    Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin.
    Kooistra MP; van Es A; Marx JJ; Hertsig ML; Struyvenberg A
    Nephrol Dial Transplant; 1994; 9(8):1115-20. PubMed ID: 7800210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.